dr. A.C. (Arno) Hessels

Cardiopulmonary Toxicity of Thoracic Radiotherapy (CLARIFY)
Funded by the Dutch Cancer Society (KWF)
This project investigates cardiopulmonary side effects in the first year after lung and oesophageal cancer chemoradiotherapy, aiming to improve risk stratification and treatment planning for patients with thoracic malignancies.

Optimized Interaction Between Chemoradiation and Immunotherapy in Stage III Inoperable Non-Small Cell Lung Cancer (IMORT)
Funded by the University Medical Center Groningen Cancer Research Foundation (KRF)
This study explores the optimal chemoradiotherapy strategy to maximize eligibility and efficacy of adjuvant immunotherapy in patients with inoperable stage III non-small-cell lung cancer (NSCLC).

IMPT-Based Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer (HyDose)
This project evaluates the potential of intensity-modulated proton therapy (IMPT) to safely escalate radiation doses in locally advanced NSCLC, with the goal of improving local control and survival outcomes.

Implementation of Proton Arc Therapy for Non-Small Cell Lung Cancer (LUARC)
This project focuses on the clinical implementation and evaluation of proton arc therapy, a novel technique that may offer improved dose conformity and reduced toxicity in the treatment of NSCLC.